Matches in Wikidata for { <http://www.wikidata.org/entity/Q91110523> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q91110523 description "2019 թվականին հրատարակված գիտական հոդված" @default.
- Q91110523 description "article scientifique (publié 2019)" @default.
- Q91110523 description "articolo scientifico (pubblicato il 2019)" @default.
- Q91110523 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q91110523 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91110523 description "im Jahr 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91110523 description "scientific article published on 01 January 2019" @default.
- Q91110523 description "wetenschappelijk artikel" @default.
- Q91110523 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q91110523 description "научна статия" @default.
- Q91110523 name "Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience" @default.
- Q91110523 name "Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience" @default.
- Q91110523 name "Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience" @default.
- Q91110523 type Item @default.
- Q91110523 label "Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience" @default.
- Q91110523 label "Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience" @default.
- Q91110523 label "Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience" @default.
- Q91110523 prefLabel "Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience" @default.
- Q91110523 prefLabel "Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience" @default.
- Q91110523 prefLabel "Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience" @default.
- Q91110523 P1433 Q91110523-C800C3B8-A0B0-4B0C-88F8-558E7BF0FB4B @default.
- Q91110523 P1476 Q91110523-F99E5329-3976-40E1-94C4-E4A0403EE923 @default.
- Q91110523 P2093 Q91110523-26822FF0-A763-4359-9C09-E80C1D9B47B9 @default.
- Q91110523 P2093 Q91110523-64237F88-0B87-4797-8333-07E772BEBE52 @default.
- Q91110523 P304 Q91110523-8436B6A8-FF44-4763-AF32-8C04A03EF055 @default.
- Q91110523 P31 Q91110523-01E12246-3EF5-4599-A2A1-E697372301C9 @default.
- Q91110523 P31 Q91110523-46e3b9c1-47b1-4234-962d-34a84a0f4eac @default.
- Q91110523 P356 Q91110523-9C6016D3-434C-4B73-B154-92D5E55B9211 @default.
- Q91110523 P478 Q91110523-26ACE7F8-A6B4-407C-ADFE-0C0DA638CD18 @default.
- Q91110523 P50 Q91110523-9C627517-1635-48D3-ABA5-F8E905B981E6 @default.
- Q91110523 P50 Q91110523-D823CBDD-F330-4DD3-A13D-03D8BA1B82BF @default.
- Q91110523 P577 Q91110523-C39A6E59-E999-45F2-A1C5-6E04360BD24D @default.
- Q91110523 P698 Q91110523-EBB32F5B-3AFC-4F9C-B73F-50A60CFBABB2 @default.
- Q91110523 P932 Q91110523-522C5037-A876-4A22-926C-69EAAB4026FB @default.
- Q91110523 P356 1753466619885530 @default.
- Q91110523 P698 31686616 @default.
- Q91110523 P1433 Q26842252 @default.
- Q91110523 P1476 "Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience" @default.
- Q91110523 P2093 "Cecile Le Pechoux" @default.
- Q91110523 P2093 "David Planchard" @default.
- Q91110523 P304 "1753466619885530" @default.
- Q91110523 P31 Q13442814 @default.
- Q91110523 P31 Q7318358 @default.
- Q91110523 P356 "10.1177/1753466619885530" @default.
- Q91110523 P478 "13" @default.
- Q91110523 P50 Q59548589 @default.
- Q91110523 P50 Q91110521 @default.
- Q91110523 P577 "2019-01-01T00:00:00Z" @default.
- Q91110523 P698 "31686616" @default.
- Q91110523 P932 "6831969" @default.